Literature DB >> 10570413

Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma.

D M Heng1, J Wee, K W Fong, L G Lian, V K Sethi, E T Chua, T L Yang, H S Khoo Tan, K S Lee, K M Lee, T Tan, E J Chua.   

Abstract

BACKGROUND: The objective of the current study was to describe the survival of nasopharyngeal carcinoma (NPC) patients in Singapore, verify the prognostic value of the revised 1997 TNM staging system, and develop a multivariate prognostic model for NPC. In addition, the authors also examined the prognostic value of characteristics of lymph node spread and parapharyngeal involvement.
METHODS: A prospectively maintained database containing clinical and computed tomography scan data was used to reclassify 677 NPC patients treated between 1992 and 1994 according to the new staging system. Records were linked with the death registry to ascertain the patient's vital status and date of death. Overall and stage specific survival were analyzed using the Kaplan-Meier method and the log rank test. Univariate and multivariate Cox proportional hazards regression analysis were used to obtain prognostic models.
RESULTS: Two hundred seventy-four deaths (40.5%) occurred. The 5-year survival rate was 56.6% (95% confidence interval [95% CI], 52.3%, 60.7%). The stage specific 5-year survival rates were: Stage I, 88%; Stage IIA, 75%; Stage IIB, 74%; Stage III, 60%; Stage IVA, 35%; and Stage IVB, 28%. TNM stage was found to be a statistically significant prognostic factor (P < 0.0001). Cranial nerve (hazard ratio [HR]: 2.77), orbit (HR: 5.71), and intracranial involvement (HR: 2.46) conferred a particularly bad prognosis in univariate analysis. Independently significant prognostic factors were age; lymph node status; and paraoropharyngeal, cranial nerve, orbit, and nasal involvement. Among lymph node positive patients, independently significant prognostic lymph node characteristics were Ho level and laterality. Although parapharyngeal involvement appeared to be prognostically unimportant, paraoropharyngeal involvement distinguished a subgroup with a poorer prognosis (HR: 1.84; 95% CI, 1.45, 2.34; P < 0.0001). Lateral spread to the medial infratemporal fossa and beyond also was found to confer a poorer prognosis.
CONCLUSIONS: The results of the current study show that the revised 1997 TNM staging system is prognostically useful. Subdivision into paraoropharyngeal involvement and using the medial infratemporal fossa to delineate prognostically significant lateral spread should be considered in future revisions. Copyright 1999 American Cancer Society.

Entities:  

Mesh:

Year:  1999        PMID: 10570413

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  48 in total

1.  Update on nasopharyngeal carcinoma.

Authors:  Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2007-11-27

2.  Association of nuclear factor κB expression with a poor outcome in nasopharyngeal carcinoma.

Authors:  Y Zhang; J Y Lang; L Liu; J Wang; G Feng; Y Jiang; Y L Deng; X J Wang; Y H Yang; T Z Dai; G Xie; J Pu; X B Du
Journal:  Med Oncol       Date:  2010-05-25       Impact factor: 3.064

3.  MRI-detected skull-base invasion: prognostic value and therapeutic implication in intensity-modulated radiotherapy treatment for nasopharyngeal carcinoma.

Authors:  Yi-Kan Cheng; Li-Zhi Liu; Ning Jiang; Dan Yue; Ling-Long Tang; Fan Zhang; Li Lin; Xu Liu; Lei Chen; Jun Ma
Journal:  Strahlenther Onkol       Date:  2014-04-25       Impact factor: 3.621

4.  Evaluation of the prognostic value of TGF-β superfamily type I receptor and TGF-β type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays.

Authors:  Wenling Zhang; Zhaoyang Zeng; Songqing Fan; Jieru Wang; Jianbo Yang; Yanhong Zhou; Xiayu Li; Donghai Huang; Fang Liang; Minghua Wu; Ke Tang; Li Cao; Xiaoling Li; Wei Xiong; Guiyuan Li
Journal:  J Mol Histol       Date:  2012-03-06       Impact factor: 2.611

5.  A new T staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results from a prospective multicentric clinical study.

Authors:  Min Kang; Pingting Zhou; Tingting Wei; Tingting Zhao; Jianxiong Long; Guisheng Li; Haolin Yan; Guosheng Feng; Meilian Liu; Jinxian Zhu; Rensheng Wang
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

6.  Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients.

Authors:  Jiang-Yi He; Ping Han; Yu Zhang; Yong-Dong Liu; Shi-Jian Song; Guo-Kai Feng; Yu An; Ai-Jun Zhou; Hong-Bo Wang; Li Yuan; Zhi-Rui Lin; Tian-Liang Xia; Man-Zhi Li; Yan-Min Liu; Xiao-Ming Huang; Hua Zhang; Qian Zhong
Journal:  J Mol Med (Berl)       Date:  2018-01-11       Impact factor: 4.599

7.  Prognostic value of interleukin-8 and MMP-9 in nasopharyngeal carcinoma.

Authors:  Daye Cheng; Hong Kong; Yunhui Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-09       Impact factor: 2.503

8.  Comparison of narrow-band imaging and conventional nasopharyngoscopy for the screening of unaffected members of families with nasopharyngeal carcinoma.

Authors:  Ching-Yin Ho; Kee-Tak Chan; Pen-Yuan Chu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-23       Impact factor: 2.503

9.  Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study.

Authors:  Z Liang; X Zhu; L Li; S Qu; X Liang; Z Liang; F Su; Y Li; W Zhao
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

10.  Retrospective analysis of results of treatment for nasopharyngeal carcinoma in Macao.

Authors:  Huiqin Dou; Dongyan Hu; Chileong Lam; Yunsheng Liu; Xiuwen Wang; Wendong Zhang
Journal:  Chin J Cancer Res       Date:  2014-04       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.